You have free access to this content

Cancer Cytopathology

Cover image for Vol. 118 Issue 4

25 August 2010

Volume 118, Issue 4

Pages 173–225

  1. CytoSource

    1. Top of page
    2. CytoSource
    3. Review Articles
    4. Editorials
    5. Original Articles
    6. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Mixed Reception for Home HPV Test (page 174)

      Bryn Nelson

      Version of Record online: 16 AUG 2010 | DOI: 10.1002/cncy.20085

    3. You have free access to this content
      A Spike in Cancer Imaging Costs (page 174)

      Bryn Nelson

      Version of Record online: 16 AUG 2010 | DOI: 10.1002/cncy.20101

      • original image
  2. Review Articles

    1. Top of page
    2. CytoSource
    3. Review Articles
    4. Editorials
    5. Original Articles
    6. Correspondence
    1. You have free access to this content
      A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis (pages 175–183)

      Nancy P. Caraway and Ruth L. Katz

      Version of Record online: 8 JUN 2010 | DOI: 10.1002/cncy.20080

      For this report, the authors summarized how urinary specimens are used in the surveillance of patients with bladder cancer. The review highlights advantages and limitations of US Food and Drug Administration-approved tests in these patients with an emphasis on the multicolor fluorescence in situ hybridization test.

  3. Editorials

    1. Top of page
    2. CytoSource
    3. Review Articles
    4. Editorials
    5. Original Articles
    6. Correspondence
    1. You have free access to this content
      Bethesda and beyond (pages 184–185)

      Edmund Cibas

      Version of Record online: 1 JUL 2010 | DOI: 10.1002/cncy.20090

      The Bethesda System for Reporting Thyroid Cytopathology has been gaining acceptance in the United States. Modifications will be made on the basis of an evolving understanding of thyroid disease and additional published evidence. Dr. Renshaw's studies are welcome additions to the growing literature on thyroid fine-needle aspiration.

  4. Original Articles

    1. Top of page
    2. CytoSource
    3. Review Articles
    4. Editorials
    5. Original Articles
    6. Correspondence
    1. You have free access to this content
      Should “atypical follicular cells” in thyroid fine-needle aspirates be subclassified? (pages 186–189)

      Andrew A. Renshaw

      Version of Record online: 28 JUN 2010 | DOI: 10.1002/cncy.20091

      Different types of “atypical follicular cells” have significantly different risks of malignancy. This varying risk should be communicated by the cytologist. See related editorial, this issue.

      Corrected by:

      Erratum: Erratum: Should “atypical follicular cells” in thyroid fine-needle aspirates be subclassified?

      Vol. 118, Issue 5, 303, Version of Record online: 9 SEP 2010

    2. You have free access to this content
      An estimate of risk of malignancy for a benign diagnosis in thyroid fine-needle aspirates (pages 190–195)

      Andrew Renshaw

      Version of Record online: 28 JUN 2010 | DOI: 10.1002/cncy.20092

      • original image
      • original image

      The best estimate of the risk of malignancy for a benign diagnosis in a thyroid fine-needle aspiration is 2.5%-3%, and this risk is affected by the percentage of benign cases that are resected.

      Corrected by:

      Erratum: Erratum: An estimate of risk of malignancy for a benign diagnosis in thyroid fine-needle aspirates

      Vol. 118, Issue 5, 303, Version of Record online: 9 SEP 2010

    3. You have free access to this content
      Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma : Diagnostic utility (pages 196–202)

      Alessandra C. Schmitt, Cynthia Cohen and Momin T. Siddiqui

      Version of Record online: 28 MAY 2010 | DOI: 10.1002/cncy.20082

      • original image
      • original image

      Paired box gene 8 (PAX8) of the thyroid-specific transcription factors has recently been investigated as a useful marker of thyroid epithelial neoplasms. However, to the authors' knowledge, its use in immunohistochemistry of papillary thyroid carcinoma has not been well studied. The results of the current study indicate that HMBE-1, cytokeratin 19, and PAX8 may all play a role, particularly as a panel, in confirming the diagnosis of papillary thyroid carcinoma.

    4. You have free access to this content
      Accuracy of liquid-based cytology : Comparison of the results obtained within a randomized controlled trial (the New Technologies for Cervical Cancer Screening Study) and an external group of experts (pages 203–208)

      Massimo Confortini, Christine Bergeron, Mina Desai, Giovanni Negri, Paolo Dalla Palma, Gioia Montanari, Antonella Pellegrini and Guglielmo Ronco

      Version of Record online: 3 JUN 2010 | DOI: 10.1002/cncy.20081

      The objective of this study was to assess whether different results could be expected with experienced interpreters of liquid-based cytology. The results indicated that previous findings on the lack of increased accuracy with liquid-based cytology compared with conventional cytology can be generalized to interpreters who have extensive experience.

    5. You have free access to this content
      Correlation between hybrid capture II high-risk human papillomavirus DNA test chemiluminescence intensity from cervical samples with follow-up histologic results : A cytologic/histologic review of 367 cases (pages 209–217)

      Stewart M. Knoepp, Diane L. Kuebler and David C. Wilbur

      Version of Record online: 24 JUN 2010 | DOI: 10.1002/cncy.20093

      • original image
      • original image
      • original image
      • original image
      • original image
      • original image
      • original image

      Results of high-risk human papillomavirus (hrHPV) testing obtained by the Hybrid Capture II test falling in the “equivocal” range are associated with a significant degree of high-grade cervical intraepithelial neoplasia (CIN). Therefore, these tests should be managed as being unequivocally positive for hrHPV. The chemiluminescence intensity of an unequivocal positive Hybrid Capture II hrHPV test does not appear to independently predict the rate of associated high-grade CIN.

    6. You have free access to this content
      Fine needle aspiration of breast masses in HIV-infected patients : Results from a large series (pages 218–224)

      Pam Michelow, Bruce J Dezube and Liron Pantanowitz

      Version of Record online: 22 JUN 2010 | DOI: 10.1002/cncy.20083

      • original image
      • original image
      • original image
      • original image
      • original image

      Fine-needle aspiration (FNA) is a useful procedure to evaluate breast lesions and is capable of rendering results useful for a broad range of diagnoses likely to be encountered in a human immunodeficiency virus (HIV)-positive population. Unlike HIV-infected females who may present with a wide range of benign and neoplastic breast entities, HIV-positive males may have breast lesions that will most likely be attributed to gynecomastia associated with antiretroviral therapy.

  5. Correspondence

    1. Top of page
    2. CytoSource
    3. Review Articles
    4. Editorials
    5. Original Articles
    6. Correspondence
    1. You have free access to this content
    2. You have free access to this content

SEARCH

SEARCH BY CITATION